3 Result(s)

Article

Correction: Discovery of a novel third-generation EGFR inhibitor and identification of a potential combination strategy to overcome resistance

Tao Zhang, Rong Qu, Shingpan Chan, Mengzhen Lai, Linjiang Tong… in Molecular Cancer (2023)

Article

Correction to: Discovery of a novel third-generation EGFR inhibitor and identification of a potential combination strategy to overcome resistance

Tao Zhang, Rong Qu, Shingpan Chan, Mengzhen Lai, Linjiang Tong… in Molecular Cancer (2021)

Article

Discovery of a novel third-generation EGFR inhibitor and identification of a potential combination strategy to overcome resistance

Non-small cell lung cancer (NSCLC) patients with activating EGFR mutations initially respond to first-generation EGFR inhibitors; however, the efficacy of these drugs is limited by acquired resistance driven b...

Tao Zhang, Rong Qu, Shingpan Chan, Mengzhen Lai, Linjiang Tong… in Molecular Cancer (2020)